Affordable Access

deepdyve-link
Publisher Website

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

Authors
  • Dirschka, T
  • Radny, P
  • Dominicus, R
  • Mensing, H
  • Brüning, H
  • Jenne, L
  • Karl, L
  • Sebastian, M
  • Oster-Schmidt, C
  • Klövekorn, W
  • Reinhold, U
  • Tanner, M
  • Gröne, D
  • Deichmann, M
  • Simon, M
  • Hübinger, F
  • Hofbauer, G
  • Krähn-Senftleben, G
  • Borrosch, F
  • Reich, K
  • And 12 more
Type
Published Article
Journal
British Journal of Dermatology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Jan 01, 2012
Volume
166
Issue
1
Pages
137–146
Identifiers
DOI: 10.1111/j.1365-2133.2011.10613.x
PMID: 21910711
Source
Medline
License
Unknown

Abstract

BF-200 ALA is a very effective, well-tolerated new formulation for AK treatment with PDT and is superior to a registered MAL medication. Efficacies and adverse events vary greatly with the different light sources used.

Report this publication

Statistics

Seen <100 times